Improved Diagnostics for Lyme Borreliosis (U01)

Post Date

March 3rd 2010

Application Due Date

April 14th 2010

Funding Opportunity Number

RFA-CK-10-005

CFDA Number(s)

93.942

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

2

Eligibility Categories

Other

Eligible Institutions You may submit an application(s) if your organization has any of the following characteristics: Public nonprofit organizations Private nonprofit organizations Small, minority, and women-owned businesses Universities Colleges Research institutions Hospitals Community-based organizations Faith-based organizations Federally recognized or state-recognized American Indian/Alaska Native tribal governments American Indian/Alaska Native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If you are applying as a bona fide agent of a state or local government, you must provide a letter from the state or local government as documentation of your status. Attach this documentation behind the first page of your application form or for electronic applications, use a PDF file and attach as “Other Documents” and label as appropriate.

Funding

• Estimated Total Funding:

  $500000

• Award Range:

  $0 - $250000

Grant Description

The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2010 funds for a cooperative agreement program for research aimed at developing and evaluating more sensitive and specific laboratory diagnostic tests for Lyme borreliosis. The purpose of the program is to bring into clinical practice laboratory tests that are superior to two-tiered serologic testing in their utility for diagnosing Lyme borreliosis and are capable of distinguishing active from prior infection.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  TIMS
  Phone 770-488-2700

• Agency Mailing Address:

  PGOTIM@cdc.gov

• Agency Email Address:

  PGOTIM@cdc.gov

• Location:

  Centers for Disease Control and Prevention